Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001951122 | SCV002240552 | pathogenic | not provided | 2024-04-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp540*) in the WFS1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 351 amino acid(s) of the WFS1 protein. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with autosomal recessive Wolfram syndrome (PMID: 21564155, 21602428, 25542043, 31313226). It has also been observed to segregate with disease in related individuals. This variant is also known as W539X. ClinVar contains an entry for this variant (Variation ID: 1456380). This variant disrupts a region of the WFS1 protein in which other variant(s) (p.Pro885Leu) have been determined to be pathogenic (PMID: 10521293, 28432734). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002497881 | SCV002810967 | likely pathogenic | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2022-03-18 | criteria provided, single submitter | clinical testing |